Begoña Campos-Balea

10PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 07, 2026
Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 study.

|Dec 23, 2025
Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial.

Mariano Provencio, Begoña Campos, María Guirado

|May 15, 2024
SEOM-GEM clinical guidelines for cutaneous melanoma (2023).

Iván Márquez-Rodas, Eva Muñoz Couselo, Juan F Rodríguez Moreno

|Jan 06, 2024
Identification of non-actionable mutations with prognostic and predictive value in patients with advanced or metastatic non-small cell lung cancer.

Mariano Provencio-Pulla, Diego Pérez-Parente, Sara Olson

|Mar 29, 2022
Follow-up of primary melanoma patients with high risk of recurrence: recommendations based on evidence and consensus.

Begoña Campos-Balea, Ovidio Fernández-Calvo, Roberto García-Figueiras

|Dec 06, 2021
Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice.

Mª Del Carmen Álamo, Sebastian Ochenduszko, Guillermo Crespo

Pageof 2

Frequent Collaborators

2 joint publications

Miguel-Ángel Berciano-Guerrero

2 joint publications

Mariano Provencio-Pulla

2 joint publications

Iván Márquez-Rodas

1 joint publications

Maria Gonzalez-Cao